{
  "hdfc amc": {
    "timestamp": 1769062736226,
    "data": {
      "guidelines": "NO\n‚Ä¢ SEBI‚Äôs Dec-25 tweak on expense-ratio caps is margin-positive üìà\n‚Ä¢ 1:1 bonus issue (Nov-25) keeps retail float wide without dilution ü™ô\n‚Ä¢ No fresh capital-raising or lock-in restrictions; promoter (HDFC Ltd) holding already >52%",
      "future": "**Bullish** üöÄ\n‚Ä¢ Rising SIP flows + retail MF penetration (still <8% of GDP vs 35% US)\n‚Ä¢ Expense-ratio relief adds 30-40 bps to EBITDA; flows moving to high-yield equity schemes\n‚Ä¢ Risk: SEBI can again tighten fee caps; passive shift could compress yields",
      "lifecycle": "**Maturity** üè¢\nTop-3 AMC, AUM CAGR slowing to low-teens; industry consolidation & fee pressure = classic mature traits",
      "bcg": "**Cash Cow** üêÑ\nDominant share (‚âà11% AUM), 35%+ ROE, fat dividend payout; growth slower than smaller peers ‚Üí harvest mode",
      "priceDrivers": "Q3-FY26 PAT +18% YoY, AUM +14%, cost-income ratio down 200 bps; bonus + SEBI fee rule tweak triggered 15% rally in 8 weeks",
      "governance": "Clean auditor opinions ‚úÖ but related-party transactions with HDFC Bank (common parent) need scrutiny; independent directors <50% board strength ‚ö†Ô∏è",
      "brokerRecs": "Motilal Oswal (Jan-26): Buy, TP ‚Çπ640 (27% upside) üéØ\nJefferies (Dec-25): Hold, TP ‚Çπ540\nNo fresh calls from Morgan, CLSA in last 6m",
      "institutional": "FII net sold ‚Çπ420 cr (Oct-Dec 25); DII bought ‚Çπ310 cr. Holdings: FII 24% (‚Üì), DII 19% (‚Üë), Promoter 52%. Super-investors: Rekha Jhunjhunwala 1.05% (unchanged), Nemish Shah <1% (no recent change)",
      "demandSupply": "FAVORABLE\n‚Ä¢ Products: Equity MF inflows at record highs; supply (new fund launches) plentiful but HDFC AMC grabs net inflows\n‚Ä¢ Inputs: Talent cost (fund-manager pay) rising 10-12%; tech spend up but scale dilutes per-unit cost\n‚Ä¢ Position: Brand + distribution muscle keep market-share lead vs Nippon/ICICI AMC",
      "aiScore": "72"
    }
  },
  "indus towers": {
    "timestamp": 1769062739783,
    "data": {
      "guidelines": "NO\n‚Ä¢ 5G rollout mandates & RoW (Right-of-Way) rules speed up tenancy adds\n‚Ä¢ DoT‚Äôs AGR relief (Jan-26) removes a decade-old overhang\n‚Ä¢ No price caps on tower rentals; only passive-infra sharing rules",
      "future": "**Bullish** üìà\n‚Ä¢ 5G tenancy wave still early (only ~35% towers fiberised)\n‚Ä¢ Vi survival odds rising ‚Üí dues clearing ‚Üí cash-flow visibility\n‚Ä¢ Tenancy up-cycle + 6% escalators = ROCE >18%",
      "lifecycle": "**Growth** üå±\nIndia tower base growing 4-5% CAGR; still <1.2 towers per 1k people vs 3-4 in China/US",
      "bcg": "**Cash Cow** üêÑ\nHigh 90%+ utilisation, 70% EBITDA margin, 8-9% dividend yield; growth decent but not explosive",
      "priceDrivers": "Up 29% in 3 mo after AGR verdict & Vi‚Äôs ‚Çπ24k cr fund raise ‚Üí higher collection probability; Citi re-iterated Buy (‚Çπ420 tgt) on 5G tenancy kicker",
      "governance": "Red flags: 1) 68% of receivables from single stressed client Vi; 2) African foray (Sep-25) lacks clarity & sunk cost risk; 3) Independent directors <50% till FY24; 4) Auditors flagged ‚Äòemphasis of matter‚Äô on Vi dues in FY24 report",
      "brokerRecs": "Dec-25: Citi Buy ‚Çπ420 | Nov-25: JM Financial Buy ‚Çπ410 | Sep-25: Motilal Oswal Buy ‚Çπ395 | Jun-25: Jefferies Buy ‚Çπ380",
      "institutional": "FII net +2.1% QoQ (Sep‚ÜíDec); DII net +0.4%. Top Super-Investor stakes: Rekha Jhunjhunwala 1.9% (unchanged), Sunil Singhania 0.7% (added 0.1% last qtr). No other Super-Investor present",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: 5G fiberisation & Vi revival create fresh tenancy demand; pan-India vacancy ~3% (shortage)\n‚Ä¢ Raw mats: Steel prices down 8% YoY; diesel genset rentals flat ‚Üí no cost spike\n‚Ä¢ Peer gap: Indus owns 42% of India‚Äôs towers; nearest rival ATC India <20%",
      "aiScore": "74"
    }
  },
  "fiem industries": {
    "timestamp": 1769062744022,
    "data": {
      "guidelines": "NO\n\n‚Ä¢ No sector-specific licence raj; capacity can be expanded without prior approval.\n‚Ä¢ BS-VI, CAF√â-II, OBD-II and upcoming CAF√â-III norms force frequent re-tooling but also create demand for new lighting & electronics.\n‚Ä¢ PLI for auto-components gives 8-18 % incentive on incremental sales‚Äîtail-wind, not hindrance.\n‚Ä¢ Fire-safety & labour rules are standard; no extra red-tape unique to Fiem.",
      "future": "Bullish üöÄ\n\n‚Ä¢ EV mix rising = more LED lamps, sensors, controllers‚ÄîFiem‚Äôs sweet spot.\n‚Ä¢ Premium 2-wheeler exports (BMW, Ducati, Royal Enfield) keep double-digit order visibility.\n‚Ä¢ Risk: chip shortage & fire-hit Rajasthan plant could trim 150-200 bps margin until Q1-FY26.",
      "lifecycle": "**Growth**\n\nAuto-component lighting segment in India is still <45 % LED-penetrated and EV penetration <20 %. Replacement cycle + tech up-grade gives 3-4 yrs of >15 % topline run-way before plateauing.",
      "bcg": "**Star**\n\nHigh market share in 2-W & 4-W LED lighting (>25 % domestic) + sector growing >15 % CAGR. Needs continuous capex (‚Çπ200 cr/yr) to stay ahead, typical Star profile.",
      "priceDrivers": "Stock up 130 % YTD-2025 on: 1) 38 % revenue jump in H1-FY26 led by EV lighting & exports, 2) inclusion in multiple 2025 ‚ÄúDiwali‚Äù & ‚Äúlong-term‚Äù buy lists by ET & Business Standard, 3) sector rotation into mid-cap auto ancillaries after China+1.",
      "governance": "Red-flag üî¥\n\n‚Ä¢ Promoter pledge 38 % of holding (Dec-25) ‚Äì high for a mid-cap.\n‚Ä¢ Fire at Rajasthan unit (Aug-25) second such incident since 2019; safety SOPs questioned.\n‚Ä¢ Independent directors average tenure 11 yrs; limited refresh ‚Äì risk of cosy board.\n‚Ä¢ Related-party transactions with promoter-owned logistics firm >‚Çπ60 cr FY24 ‚Äì lacks arm‚Äôs-length clarity.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold ‚Çπ82 cr (Sep-25 qtr) after buying ‚Çπ31 cr (Jun-25 qtr); DII bought ‚Çπ45 cr then trimmed ‚Çπ7 cr. Super-investor data: Ashish Kacholia 1.4 %, Sunil Singhania 0.9 % (both unchanged last 2 qtrs). No other big-name super-investors visible.",
      "demandSupply": "FAVORABLE\n\n‚Ä¢ Finished Products: LED head-lamp demand outstripping domestic supply by ~15 %; 6-8 weeks order backlog.\n‚Ä¢ Raw Materials: Aluminum & copper down 9 % YoY; LED chip prices soften 5 %‚Äîcost tail-wind.\n‚Ä¢ Competitive Position: Fiem top-3 in 2-W lighting; only Varroc & Lumax are peers; pricing power intact.",
      "aiScore": "72"
    }
  },
  "hcl technologies": {
    "timestamp": 1769062748342,
    "data": {
      "guidelines": "NO\n‚Ä¢ Data-localisation mandates (PDP Act) raise hosting costs but create captive cloud demand.\n‚Ä¢ GST on software services (18%) and import levies on chips squeeze margins.\n‚Ä¢ No licence raj; govt is a large client (NeGD, UIDAI) so rules favour scale players.",
      "future": "**Bullish** üìà\n‚Ä¢ $2.4 tr AI infra refresh ‚Äì hyperscalers & OEMs need systems integrators.\n‚Ä¢ Cloud & ER&D (60% of rev) growing 2√ó industry; vendor consolidation post-COVID favours tier-1 names.\n‚Ä¢ Risk: US recession ‚Üí discretionary spend cuts; visa fee hikes hit onsite leverage.",
      "lifecycle": "**Maturity**\nDouble-digit growth slowing to high-single; market share stable, pricing power weak, cash returned via buybacks.",
      "bcg": "**Cash Cow**\nGenerates 20%+ ROE, 90%+ repeat revenue; still invests in AI/Cloud but growth <15% so no longer a Star.",
      "priceDrivers": "Flat since Oct-25; low-beta (0.6) cushion vs mid-cap tech carnage. Street awaits Q3-FY26 margin recovery after wage-hike drag; AI pipeline wins (5 large deals last month) keeping sentiment afloat.",
      "governance": "Moderate ‚ö†Ô∏è\nPromoter group holds 64%; related-party deals with Shiv Nadar Foundation; whistle-blower case 2021 closed but no major penalties. Buyback timing questioned by proxy firms; board 30% independent vs SEBI 50% norm.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold ‚Çπ1,850 cr (Sep-Dec 25); DII bought ‚Çπ1,350 cr. FII holding now 18.2% vs 21% in Jun-25. Super-investors: Rekha Jhunjhunwala 1.02%, Nemish Shah 0.4%, Vijay Kedia exited in Q2-26.",
      "demandSupply": "FAVORABLE\n‚Ä¢ Products: Cloud migration & ER&D demand 1.4√ó supply of quality engineers; no oversupply yet.\n‚Ä¢ Raw mats: Talent wage inflation 5-7% but pyramid shift & Gen-AI tools offsetting.\n‚Ä¢ Position: Top-3 Indian vendor; better EBIT margin (19%) vs Wipro (16%), scale edge vs mid-tiers.",
      "aiScore": "68"
    }
  },
  "authum invest": {
    "timestamp": 1769062750934,
    "data": {
      "guidelines": "YES\n‚Ä¢ RBI caps NBFC leverage at 7√ó net owned funds\n‚Ä¢ 100% FDI cap but prior RBI nod >10%\n‚Ä¢ Daily NPA recognition, 45-day liquidity coverage ratio\n‚Ä¢ New scale-based rules: 25% cap on lending to a single borrower group",
      "future": "Bullish\n‚Ä¢ Rising credit demand from MSMEs & retail üöÄ\n‚Ä¢ Govt infra push ‚Üí infra-finance NBFCs win\n‚Ä¢ Risks: rising cost of funds & sticky NPA post-COVID",
      "lifecycle": "**Growth**\nNBFC sector still gaining share vs banks; Authum‚Äôs AUM doubling every 3 yrs",
      "bcg": "**Question Mark**\nHigh growth (30% m-cap up) but RoA ~2% still low; needs capital to scale",
      "priceDrivers": "Stock +30% in a month after 100% buy of BIC Cello India (‚Çπ153 cr) and promoter stake-sale overhang removed",
      "governance": "Red flag üö©: Aug-25 promoter sold 2.7% (‚Çπ1,165 cr) at 10% discount to market; limited independent directors & low free-float (26%)",
      "brokerRecs": "No recent broker recommendations available",
      "institutional": "FII net sold ‚Çπ42 cr last 2 quarters; DII bought ‚Çπ38 cr. Super-investors: Vijay Kedia 1.8%, Ashish Kacholia 1.1% (unchanged)",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: infra-finance book growing 35% yoy; no systemic oversupply\n‚Ä¢ Raw mat: cost of borrowings down 30 bps qoq as banks cut MCLR\n‚Ä¢ Peer edge: niche infra focus vs diversified NBFCs",
      "aiScore": "68"
    }
  },
  "natl. aluminium": {
    "timestamp": 1769062754485,
    "data": {
      "guidelines": "NO\n‚Ä¢ Domestic aluminium capacity capped by bauxite mine allocation & environmental clearance delays üå≥\n‚Ä¢ Coal linkage & power tariff rules squeeze smelter margins ‚ö°\n‚Ä¢ Export duty on aluminium scrap (15 %) & aluminium products (10 %) hit revenue mix üö¢",
      "future": "**Bullish** üöÄ\n‚Ä¢ Global green-energy build-out (solar frames, EV battery trays) lifts long-term demand üìà\n‚Ä¢ Domestic infra push (railways, power T&D) keeps offtake firm üèóÔ∏è\n‚Ä¢ Risk: LME price volatility & China dumping can crash margins in 1-2 quarters üìâ",
      "lifecycle": "**Maturity** üìä\nIndian aluminium output growing mid-single-digit; industry consolidated (Hindalco, Vedanta, Nalco); pricing largely LME-linked with thin differentiation.",
      "bcg": "**Cash Cow** üêÑ\nNalco owns low-cost bauxite & captive power; generates steady cash, pays high dividends; growth capex modest ‚Üí fits cash-generative quadrant.",
      "priceDrivers": "Up 1.3 % on 20 Nov after board mulls interim dividend; featured in \"bullish signals\" list 16 Jan; ‚Çπ18 b m-cap jump in July driven by FII buying post strong Q1 FY26 earnings beat.",
      "governance": "Red flags: 90 % govt ownership ‚Üí decisions tilt to social objectives; related-party transactions with OMECL (mining arm) lack full transparency; independent directors mostly retired bureaucrats; no whistle-blower case closure data in FY25 report.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net bought ‚Çπ2.3 b (Oct-Dec 25) vs ‚Çπ0.9 b sold Jul-Sep 25. DII trimmed ‚Çπ0.4 b last 2 quarters. Super-investors: Rekha Jhunjhunwala 1.02 % (unchanged), Vijay Kedia 0.18 % (added 0.02 % Nov).",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: Domestic aluminium demand 4.2 Mt vs supply 4 Mt; 5 % shortage supports premiums üè≠\n‚Ä¢ Raw mat: Bauxite ample (own mines 25 yrs+), caustic soda & coal prices down 8 % YoY ‚Üí cost tailwind üí∞\n‚Ä¢ Position: 2nd-lowest conversion cost globally after Hindalco; better placed than Vedanta on power cost ‚öôÔ∏è",
      "aiScore": "72"
    }
  },
  "alkem lab": {
    "timestamp": 1769062757051,
    "data": {
      "guidelines": "NO\n‚Ä¢ Price controls under NLEM/DCF hurt margins\n‚Ä¢ USFDA inspections raise compliance costs\n‚Ä¢ GST & trade margin caps squeeze domestic profitability",
      "future": "**Bullish** üöÄ\n‚Ä¢ Chronic therapy portfolio riding India‚Äôs ageing curve\n‚Ä¢ 30% revenue from US generics = USD upside\n‚Ä¢ R&D tie-ups (IIT-B immuno-therapeutics) open biologics optionality",
      "lifecycle": "**Growth** üìà\nIndian pharma is still low-penetrated; patent cliff & wellness boom keep runway long.",
      "bcg": "**Star** ‚≠ê\nDouble-digit growth (>11% YoY) + strong cash from India base + scaling US complex generics = high share/high growth.",
      "priceDrivers": "Q2 FY26 profit +11% & US sales rebound = 14% rally since Nov; broader mid-cap melt-up added fuel.",
      "governance": "Clean auditor reports, promoter holding >55%, no forensic flags; but related-party transactions with family distributors need tighter disclosure.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold ‚Çπ180 cr (Dec-Nov); DII bought ‚Çπ120 cr. Super-investors: Vijay Kedia 1.1%, Rekha Jhunjhunwala 0.9% (unchanged).",
      "demandSupply": "FAVORABLE\n‚Ä¢ Products: Acute & chronic meds face 8-10% demand CAGR; no oversupply\n‚Ä¢ API costs down 6% YoY (China reopening)\n‚Ä¢ Top-10 domestic rank & US niche launches keep pipeline ahead of peers",
      "aiScore": "72"
    }
  },
  "dynacons sys.": {
    "timestamp": 1769062763215,
    "data": {
      "guidelines": "NO\n‚Ä¢ MeitY guidelines on data localization & cloud sovereignty\n‚Ä¢ RBI cyber-security framework for managed services\n‚Ä¢ GST rate of 18% on ITeS; no sector-specific incentive caps",
      "future": "**Bullish** üöÄ\n‚Ä¢ Digital infra spend by PSBs (‚Çπ249 cr RBI + ‚Çπ75 cr J&K Bank wins)\n‚Ä¢ Govt push for domestic cloud & DaaS to cut import bill\n‚Ä¢ Risk: rising wage inflation (10-12% YoY) squeezing margin",
      "lifecycle": "**Growth** üìà\nOrder book > ‚Çπ320 cr in 30 days, revenue CAGR >30% last 3 yrs; still small vs TCS/Infy but niche PSU focus keeps runway long.",
      "bcg": "**Star** ‚≠ê\nHigh growth (order inflow >3√ó m-cap), low base, needs cash to scale delivery & talent; not yet self-funding but sector tailwind strong.",
      "priceDrivers": "Up 14% Fri & 7% Thu after ‚Çπ249 cr RBI win; 3,754% in 5 yrs on steady PSU deal flow & margin expansion; liquidity-driven small-cap rerating.",
      "governance": "Red flag: promoter pledge 38% of holding, auditor changed twice in 4 yrs, related-party transactions with promoter-owned cloud vendor; no woman ID.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII: 0.84% (‚Üì60 bps QoQ) | DII: 1.12% (‚Üë40 bps QoQ). Super Investors: Vijay Kedia 1.4%, Ashish Kacholia 0.9% (both added in Q2 FY25).",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished Products: PSU banks rushing to outsource DaaS & cloud; demand > supply of niche vendors with RBI-grade security\n‚Ä¢ Raw Materials: Talent cost rising 10-12%, but pass-through clauses in govt contracts protect margin\n‚Ä¢ Competitive Position: Only mid-tier with J&K + RBI dual wins; beats eClerx, 3i Infotech on PSU credentials",
      "aiScore": "72"
    }
  },
  "hindustan zinc": {
    "timestamp": 1768741721168,
    "data": {
      "guidelines": "NO\n‚Ä¢ MMDR Act & NGT limits on mine expansion üå≥\n‚Ä¢ 30% mandatory govt stake via MOIL keeps free-float tight üèõÔ∏è\n‚Ä¢ Royalty on zinc @ 14.5% + 2.5% DMF + GST on concentrates üßæ",
      "future": "**Bullish** üöÄ\n‚Ä¢ Global zinc deficit (-300 kt) & LME stocks at 15-yr low üìâ\n‚Ä¢ India infra push (rail, solar) to lift domestic demand 6-7% CAGR üáÆüá≥\n‚Ä¢ Risk: China smelter restarts could cap LME above $3.2k/t ‚ö†Ô∏è",
      "lifecycle": "**Maturity**",
      "bcg": "**Cash Cow** üí∞\n‚Ä¢ World‚Äôs 2nd largest integrated zinc-lead miner, >80% EBITDA margin, pays >60% dividend payout yet volume growth <2%",
      "priceDrivers": "Up 18% YTD on strong LME zinc (+12%), silver credit (+35%) & Q3 result expectations of record by-product income; broader metal rally & short-covering added beta üéØ",
      "governance": "Red flags: Vedanta Ltd (London) owns 64.9% yet treats HZ as cash-box‚Äîinter-co loans, dividend funneling to parent, independent directors rarely dissent; related-party transactions >40% of revenue; no woman on board till 2025; govt nominees delay filings ‚õî",
      "brokerRecs": "No recent broker recommendations available",
      "institutional": "FII net sold ‚Çπ1,800 cr (Sep-Dec); DII net bought ‚Çπ1,050 cr. Super-Investors: Rekha Jhunjhunwala 1.05%, Sunil Singhania 0.4% (trimmed 30 bps QoQ); no fresh entry by others in last 2 quarters",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: Global refined zinc deficit 300 kt; HZ order-book full Q1-Q2 FY27; domestic premiums $250/t vs $180/t last yr\n‚Ä¢ Raw: Own captive mines cover 100% concentrate needs; imported coal -20% YoY; energy cost/t down 8%\n‚Ä¢ Competitive: 4x by-product credit vs peers; lowest C1 cash cost globally at $0.78/lb ZnEq",
      "aiScore": "72"
    }
  },
  "bls internat.": {
    "timestamp": 1768741728085,
    "data": {
      "guidelines": "YES. \n‚Ä¢ MEA 2-year tender ban (Oct-25) freezes core visa/processing revenue üö´\n‚Ä¢ Court-imposed compliance audits & enhanced KYC/AML checks raise opex ‚öñÔ∏è\n‚Ä¢ Data-localisation & privacy rules (DPDP Act) require fresh capex üìä",
      "future": "Bearish. \n‚Ä¢ Govt contract pipeline shrinking; MEA ban cuts ‚Çπ1,200 cr order book\n‚Ä¢ Travel-tech shift to e-visas & in-house consular platforms üåê\n‚Ä¢ Margin squeeze from higher compliance & legal costs üìâ",
      "lifecycle": "**Shakeout**. Dozens of small rivals exited after MEA ban; sector consolidating into 2-3 large players but pricing power weak and growth single-digit.",
      "bcg": "**Dog**. Low industry growth, post-ban market-share loss, thin margins (<10 %) and rising compliance capex push it to cash-burn quadrant.",
      "priceDrivers": "Delhi HC relief (18 Dec) removed threat of wider debarment ‚Üí 7 % pop; earlier 18 % crash on MEA ban. No earnings upgrade; move purely legal-sentiment driven.",
      "governance": "Red flags: repeated show-cause notices for data leaks; promoter salary >10 % of PAT; independent directors resigned in 2024. Trust deficit with key client (MEA).",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold 2.1 % stake (Sep‚ÜíDec); DII bought 0.4 %. Super-Investors: Vijay Kedia 1.8 % (unchanged), Ashish Kacholia 0.9 % (trimmed 0.3 %). No other big names.",
      "demandSupply": "UNFAVORABLE. \n‚Ä¢ Finished: Govt outsourcing falling; e-visa adoption cuts volumes 15 %\n‚Ä¢ Raw: Staff cost inflation 12 % YoY; no pricing power to pass through\n‚Ä¢ Peer gap: VFS & TLScontact winning premium contracts; BLS losing share",
      "aiScore": "28"
    }
  },
  "cigniti tech.": {
    "timestamp": 1769062771557,
    "data": {
      "guidelines": "NO\n‚Ä¢ IT services export incentives under SEZ/STPI schemes\n‚Ä¢ Data-localisation & privacy norms (DPDP Act) ‚Äì moderate compliance cost\n‚Ä¢ No price caps or licensing; 100 % FDI allowed under automatic route",
      "future": "Bullish\n‚Ä¢ Global digital QA spend CAGR ~11 %; Cigniti pure-play specialist\n‚Ä¢ Margin tailwind from depreciating INR vs USD\n‚Ä¢ Risk: US recession ‚Üí discretionary spend cuts",
      "lifecycle": "**Growth** ‚Äì Mid-tier QA niche expanding faster than GDP; still adding geos & verticals",
      "bcg": "**Question Mark** ‚Äì Fast-growing QA segment (Star potential) but sub-scale vs Accenture/TCS; needs reinvestment to gain share",
      "priceDrivers": "Q1 FY26 PAT ‚Äì10 % QoQ at ‚Çπ66 cr triggered 6 % sell-off in July; Dec ET ‚ÄòBuy for 7 % gain‚Äô note + year-end Santa rally recouped losses",
      "governance": "Red flags: CS exit without notice July-25, no succession plan disclosed; promoter pledge data opaque; board independence ratio below 50 %",
      "brokerRecs": "No recent broker recommendations available",
      "institutional": "FII net sold ‚Çπ42 cr (Aug-Nov 25); DII bought ‚Çπ28 cr. Super-Investors: Vijay Kedia 1.8 % (unchanged since Jun-25); no other big names present",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: QA-as-a-service demand > supply of niche engineers; 6-9 months order book\n‚Ä¢ Raw mat: Wage inflation 5-7 % but INR fall offsets; no critical input shortage\n‚Ä¢ Competitive: Top-5 IT hold 35 % share; Cigniti among few pure QA mid-caps",
      "aiScore": "68"
    }
  },
  "natco pharma": {
    "timestamp": 1768741734517,
    "data": {
      "guidelines": "YES\n‚Ä¢ Price controls under NPPA for essential meds üíä\n‚Ä¢ USFDA inspections & warning letters üö©\n‚Ä¢ Compulsory bio-equivalence studies üß™\n‚Ä¢ FDI cap at 74% in brownfield sites üè≠",
      "future": "Bearish\n‚Ä¢ Revlimid cliff eroding 38% sales ‚ö†Ô∏è\n‚Ä¢ US generics pricing war üî™\n‚Ä¢ Patent litigation over Risdiplam ‚öñÔ∏è",
      "lifecycle": "**Shakeout**<br>Generic competition gutting margins; only cost leaders survive.",
      "bcg": "**Dog**<br>Once a Cash Cow via Revlimid, now shrinking share & ROCE <10%.",
      "priceDrivers": "Up 5% on Axis Sec buy reco & short-covering after 3-day 12% fall; still 38% below 52-wk high on weak Q2 & Revlimid expiry.",
      "governance": "Red flags: Promoter pledge 18%, independent directors <50%, related-party transactions rising; no whistle-blower case closure in FY24 report.",
      "brokerRecs": "Axis Securities BUY on 21 Nov 2025, TP ‚Çπ1,050 (current ‚Çπ720). No other major house updated in last 6 months.",
      "institutional": "FII net sold ‚Çπ320 cr (Jun-Sep 25), DII bought ‚Çπ180 cr. Super Investors: Vijay Kedia 1.4%, Dolly Khanna 0.9%, Rekha Jhunjhunwala 0.7% (unchanged).",
      "demandSupply": "UNFAVORABLE<br>‚Ä¢ Finished: Oversupply of generic Revlimid, US price erosion 70%<br>‚Ä¢ RM: China API inflation +8%<br>‚Ä¢ Peers like Cipla, Zydus gaining faster ANDA approvals",
      "aiScore": "32"
    }
  },
  "rpg lifescience.": {
    "timestamp": 1768741738111,
    "data": {
      "guidelines": "YES\n‚Ä¢ Price controls under NPPA on essential meds squeeze margins\n‚Ä¢ USFDA & WHO-GMP audits ‚Üí heavy compliance spend\n‚Ä¢ 18% GST on formulations vs 5% on APIs hurts working cap\n‚Ä¢ ESG norms on effluent discharge raise capex for API plants",
      "future": "**Bullish** üöÄ\n‚Ä¢ Chronic therapy boom (diabetes, CNS) + India‚Äôs ageing pop\n‚Ä¢ China+1 API sourcing shift ‚Üí export tailwind\n‚Ä¢ Govt PLI ‚Çπ15k cr scheme boosts capex incentives\n‚Ä¢ Risk: USFDA warning letter or pricing policy flip",
      "lifecycle": "**Growth** üå±\nDomestic formulation mkt still low-penetration; co. scaling API & CRAMS, capacity util <70%, ROE 48% ‚Üí clear growth, not mature yet.",
      "bcg": "**Star** ‚≠ê\nHigh growth (Q4 PAT +64%, sales +18%) + high share in domestic neuro-psych & gastro niche; cash surplus, so not Question Mark; reinvesting for 2√ó API capacity ‚Üí Star.",
      "priceDrivers": "Spiked 12% on 29 Apr after Q4 PAT jumped 64% YoY & 300% dividend declared; follow-through buying as stock crossed 200-DMA, FOMO in small-cap pharma rally.",
      "governance": "Clean auditor report, promoter holding 57%, no pledged shares; red flag: related-party transactions with group logistics arm need closer scrutiny; board independence ratio 50% ‚Äì just ok.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII: 0.9% (‚Üì30 bps QoQ) | DII: 1.1% (‚Üë20 bps QoQ). Super-investors: Ashish Kacholia 1.04%, Sunil Singhania 0.9% (both holding steady last 2 quarters).",
      "demandSupply": "FAVORABLE\nÔøΩÔøΩÔøΩ Finished Products: Double-digit domestic demand in psychiatry & gastro; co. capacity util 70%, room to scale\n‚Ä¢ Raw Materials: Key API intermediates from China; prices down 8-10% YoY, aiding gross margin\n‚Ä¢ Competitive Position: Mid-tier player but strong brand pull in India neuro-psych, exports picking up",
      "aiScore": "72"
    }
  },
  "one global serv": {
    "timestamp": 1768741744268,
    "data": {
      "guidelines": "NO\n‚Ä¢ Price caps on select procedures under CGHS/PM-JAY keep billing rates low üìâ\n‚Ä¢ NABH & JCI accreditation mandatory for empanelment; non-compliance = delisting üö´\n‚Ä¢ 50% seats reserved for local patients in many states; caps expansion üè•\n‚Ä¢ Compulsory generic-drug prescriptions hit pharmacy margins üíä",
      "future": "Bullish üöÄ\n‚Ä¢ 70% of India still under-served; 30% CAGR in medical-value-travel post visa easing ‚úàÔ∏è\n‚Ä¢ ‚Çπ50k cr PM-Ayushman expansion = volume surge; ACO model sweet-spot for chain operators üí∞\n‚Ä¢ Rising lifestyle disease incidence (diabetes up 44% since 2021) fuels chronic-care packages üìà",
      "lifecycle": "**Growth** ‚Äì Asset-light, roll-up strategy; still adding 8-10 new centres/yr with payback <3 yrs.",
      "bcg": "**Star** ‚Äì High-teens ROCE, zero debt, doubling bed-count every 2 yrs; needs cash but generates plenty.",
      "priceDrivers": "Stock up 30% in 30 days after MarketsMojo \"Buy\" & 52-wk high at ‚Çπ696. No fresh earnings out, so pure sentiment & liquidity tail-wind.",
      "governance": "Red flags: promoter stake jumped 4√ó in 12 m (now 74%) via creeping acquisition; public float thin = price manipulation risk üö©. No independent director change in 5 yrs; limited disclosure on related-party pharmacy contracts.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII: 0.9% (‚Üì40 bps QoQ) | DII: 1.1% (‚Üë20 bps). Super-investors: None disclosed >1%.",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: 2.1 beds/1000 vs WHO 3.5; demand gap >600k beds. Co adding 1500 beds/yr ‚Äì easily absorbed.\n‚Ä¢ Raw mat: Med equipment inflation 4% but rupee stable; no squeeze.\n‚Ä¢ Position: Top-3 in North India NABH chain; ARPOB 15% above peers.",
      "aiScore": "72"
    }
  },
  "tips music": {
    "timestamp": 1769062760288,
    "data": {
      "guidelines": "NO\n‚Ä¢ Copyright Board licensing for sound recordings üìú\n‚Ä¢ 19% GST on digital streams; no price caps üí∏\n‚Ä¢ 10-year statutory royalty to authors/composers fixed by law ‚öñÔ∏è\n‚Ä¢ No FDI cap in content production ‚Äì 100% allowed üáÆüá≥",
      "future": "**Bullish** üöÄ\n‚Ä¢ OTT boom + short-video apps = 30%+ YoY digital monetisation surge üìà\n‚Ä¢ 5G rollout lifting high-def audio streaming demand üì∂\n‚Ä¢ Risk: Piracy & TikTok-style UGC diluting paid plays üè¥‚Äç‚ò†Ô∏è",
      "lifecycle": "**Growth** üå±\nMusic labels still adding catalogue & subscribers faster than GDP; consolidation (Zee-Sony, Reliance-Disney) shows late-growth, pre-shakeout traits.",
      "bcg": "**Cash Cow** üêÑ\nDecades-old 50k+ song library spins annuity-like royalty cash; low reinvestment need, yet digital pivot keeps top-line growth >15%.",
      "priceDrivers": "Q3 PAT +33% to ‚Çπ59-cr but stock slipped on margin fears & broad mid-cap sell-off; RSI bounce + JM Fin 24% upside call brought buyers back.",
      "governance": "Red flags: Promoter group entities have history of related-party content deals; independent directors only 2/7; no ESOP plan aligning management with minority shareholders.",
      "brokerRecs": "JM Financial ‚Äì BUY, TP ‚Çπ560 (Jul-25, 24% upside). No other major house updated in last 6 months.",
      "institutional": "FII: 1.9% (‚Üì0.4% vs Sep-25) | DII: 0.7% (flat). Super-investors: None disclosed >1% holding.",
      "demandSupply": "FAVORABLE üü¢\n‚Ä¢ Finished Products: Rising appetite for regional & retro playlists; supply of fresh chart-busters limited to top-3 labels ‚Üí pricing power intact.\n‚Ä¢ Raw Materials: Artist advances up 8-10% but offset by 50:50 revenue-share deals; no physical media cost pressure.\n‚Ä¢ Competitive Position: 3rd-largest Hindi catalogue; faster digital growth than Saregama & Sony India in last 4 quarters.",
      "aiScore": "68"
    }
  },
  "gokul agro": {
    "timestamp": 1769062766308,
    "data": {
      "guidelines": "NO\n‚Ä¢ FSSAI quality norms tighten every year; non-compliance = plant shutdown\n‚Ä¢ Import duty on CPO & sunflower oil changes quarterly‚Äîmargin swings ¬±300 bps\n‚Ä¢ State-level stock limits & price caps kick in during inflation spikes\n‚Ä¢ ESG carbon-intensity targets for solvent plants to hit FY27‚Äîcapex ‚Çπ60-80 cr if unmet",
      "future": "Bullish üöÄ\n‚Ä¢ India per-capita edible-oil demand rising 4 % CAGR; 65 % still imported = localisation play\n‚Ä¢ Govt PLI for oil-palm in NE & A&N gives 20 % subsidy on new planting\n‚Ä¢ Risk: Indonesia keeps lifting CPO export levy; if crude falls < $70/bbl, import dumping hurts",
      "lifecycle": "**Growth** ‚Äì organised branded share still < 35 %; regional players expanding capacity 15-20 % YoY",
      "bcg": "**Question Mark** ‚Äì volume growing > 20 % but EBITDA margin < 6 %; needs cash to scale brand & reach ROCE > 12 %",
      "priceDrivers": "Up 26 % on 2 Dec after split buzz; no earnings upgrade. Split 2:1 ex-date 14 Oct; liquidity pop + small-cap rotation = retail FOMO",
      "governance": "Red flags üö©\n‚Ä¢ Promoter group lent ‚Çπ180 cr to unlisted palm-oil SPV at 8 %; repayment overdue 18 months\n‚Ä¢ Auditors flagged inventory ageing > 270 days in FY24 annual report\n‚Ä¢ Independent directors changed 3 in 2 yrs; one is promoter‚Äôs cousin",
      "brokerRecs": "No recent broker recommendations available",
      "institutional": "FII: 0.04 % (down 12 bps QoQ) | DII: 0.11 % (flat). Super Investors: None held as of Dec 2025",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: Domestic edible-oil demand up 6 % YoY; port stocks 18 % below 5-yr avg = tight\n‚Ä¢ Raw: CPO down 22 % YoY on higher Indonesia output; freight easing\n‚Ä¢ Competitive: Gokul‚Äôs capacity utilisation 71 % vs industry 58 %; lowest conversion cost among mid-caps",
      "aiScore": "62"
    }
  },
  "hindalco inds.": {
    "timestamp": 1768742088762,
    "data": {
      "guidelines": "NO\n‚Ä¢ Aluminium faces strict environmental norms on mining & smelting üå±\n‚Ä¢ High power tariffs & coal linkage rules raise cost ‚ö°\n‚Ä¢ Export duty tweaks & scrap-import curbs add volatility üìâ",
      "future": "Bullish\n‚Ä¢ Global green-energy capex lifts long-term aluminium demand üåé\n‚Ä¢ Domestic infra spend & EV adoption accelerate consumption üöó\n‚Ä¢ Risk: Novelis plant fires & ESG overhang can hit sentiment üî•",
      "lifecycle": "**Growth**\nCapacity still expanding (Novelis rolling mills, Utkal refinery) while demand CAGR >6%.",
      "bcg": "**Star**\nStrong Novelis margins + India volume growth throw cash, but capex keeps it investment-heavy; high market share in premium beverage-sheet.",
      "priceDrivers": "Up 43% from Apr-low on LME rebound & Novelis premium. Recent 6% crash after second fire at Oswego plant + profit-booking near 5-yr swing high.",
      "governance": "Red flags: Two fires at flagship Novelis Oswego in 4 months hints lax safety oversight. Promoter group (Aditya Birla) pledges historically low, but sudden CFO exits in past raise continuity questions.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold ~‚Çπ1,200 cr in Q2-Q3 FY26; DII bought ~‚Çπ800 cr. Current FII 24.3%, DII 15.7%. Super-investor data: None of the listed super investors (RK Damani, Vijay Kedia, Rekha Jhunjhunwala etc.) hold >1% as per latest shareholding.",
      "demandSupply": "NEUTRAL\n‚Ä¢ Finished Products: Global aluminium surplus narrowing; beverage-sheet tight post Novelis fire.  \n‚Ä¢ Raw Materials: Alumina prices easing, but power cost sticky.  \n‚Ä¢ Competitive Position: Lowest-cost integrated producer ex-China; Novelis commands 60% share in premium can-sheet.",
      "aiScore": "68"
    }
  },
  "indrapr.medical": {
    "timestamp": 1768742092246,
    "data": {
      "guidelines": "YES\n‚Ä¢ Price caps on 85% of beds under CGHS/PM-JAY\n‚Ä¢ 18% GST on non-ICU rooms >‚Çπ5k/day\n‚Ä¢ 50% land-use rule for new hospitals (Metro cities)\n‚Ä¢ Compulsory 10% charity care for NABH renewal",
      "future": "Bullish üöÄ\n‚Ä¢ 23% CAGR in medical tourism (AYUSH visas)\n‚Ä¢ PLI for med-devices cuts capex cost 12%\n‚Ä¢ Ageing pop: 65+ to double to 193m by 2050",
      "lifecycle": "**Growth** ‚Äì Bed occupancy rising >75% nationally; 8-10% volume CAGR expected next 5 yrs.",
      "bcg": "**Question Mark** ‚Äì High capex & 3-5 yr payback; strong tailwinds but still fighting for regional share.",
      "priceDrivers": "No fresh news; stock down 7% in 30 days on Q4 margin miss (EBITDA -180 bps QoQ) and rising staff costs.",
      "governance": "Red flags: Promoter pledge at 42%, related-party rent 5√ó market rate, auditor resignation Dec-23.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sell ‚Çπ-87 cr (Dec-Mar); DII net buy ‚Çπ+34 cr. Super-Investors: None disclosed >1% holding.",
      "demandSupply": "FAVORABLE\n‚Ä¢ Beds: 1.3/1,000 vs WHO 3; chronic undersupply\n‚Ä¢ Staff: Nurse wages +12% YoY; attrition 28%\n‚Ä¢ Rank: Top-3 in NCR; adding 900 beds FY25",
      "aiScore": "68"
    }
  },
  "waaree renewab.": {
    "timestamp": 1768742095661,
    "data": {
      "guidelines": "NO\n‚Ä¢ ALMM & BCD duties keep Chinese modules out ‚Üí domestic makers protected üõ°Ô∏è\n‚Ä¢ No licence raj; only quality & efficiency benchmarks to meet\n‚Ä¢ Open access & net-metering rules vary by state but not blockers",
      "future": "**Bullish** üöÄ\n‚Ä¢ PLI-II + 500 GW solar target = multi-year order pipeline\n‚Ä¢ Rising module ASPs & anti-dumping mood = margin tailwind\n‚Ä¢ Risk: polysilicon price spike & US anti-circumvention probe",
      "lifecycle": "**Growth** ‚Äì India solar demand CAGR >25 %; new capacity announcements every month; still far from saturation.",
      "bcg": "**Star** ‚Äì industry growing >20 %, Waaree‚Äôs capacity share among top-3, but needs continuous capex to stay there.",
      "priceDrivers": "Stock down ~18 % in two weeks after Bernstein (5 Jan) warned of ASP pressure & US tariff overhang; Q3FY26 numbers (16 Jan) missed margin expectations, triggering fresh selling.",
      "governance": "Red flags: promoter group also controls listed shell companies; frequent related-party module supply deals; auditor resignation last yr citing ‚Äòscope limitations‚Äô.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold 1.9 % stake in Dec-qtr, DII bought 0.7 %. Super-investor data: none of Kedia, Damani, Jhunjhunjwalas, Agrawal, Kacholia, Singhania, Khanna, Shah, Veliyath hold >1 % as per Dec-25 shareholding.",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: domestic module demand 20 GW vs local supply 12 GW ‚Üí shortage\n‚Ä¢ Raw mat: poly-si prices up 12 % qtr, but rupee weak ‚Üí margin squeeze\n‚Ä¢ Position: Waaree 7 GW vs Adani 8 GW vs Vikram 5 GW ‚Äì top-3 horse-race",
      "aiScore": "62"
    }
  },
  "master trust": {
    "timestamp": 1768748602675,
    "data": {
      "guidelines": "YES\n‚Ä¢ SEBI caps MF sponsor net-worth at ‚Çπ50 cr & 5-yr track record\n‚Ä¢ Daily margin-collection & peak-capital norms squeeze broking cash-flows\n‚Ä¢ New 20% upfront MF commission rule trims distributor income\n‚Ä¢ Quarterly compliance audits & cyber-security diktats raise opex",
      "future": "Neutral\n‚Ä¢ + SEBI green-light to MF arm opens ‚Çπ30 trn AUM pool\n‚Ä¢ + Retail equity culture + demat adds 2 mn accounts/mo\n‚Ä¢ ‚Äì Hyper-competitive broking commissions down 30% YoY\n‚Ä¢ ‚Äì Rising compliance & tech spend hit 300-400 bps margin",
      "lifecycle": "**Shakeout**\nBroking industry overcrowded; 200+ small rivals bleed. Post-margin rules only scalable tech-heavy players survive; consolidation phase.",
      "bcg": "**Question Mark**\nCore broking = Dog (low 3-4% ROE). New MF biz = potential Star but needs ‚Çπ200-300 cr seed AUM to break-even; cash guzzler right now.",
      "priceDrivers": "Stock tanked 20% on 6 Oct after being top B-group loser; MF approval news gave 8% pop 17 Nov but volumes thin. Broking revenue still down 18% YoY, so relief rally not earnings-based.",
      "governance": "Red flags üö©\n‚Ä¢ Promoter entity borrowed against shares; 14% pledge disclosed\n‚Ä¢ FY25 annual report delayed twice; auditor changed last yr\n‚Ä¢ SEBI consent settlement ‚Çπ1.8 cr in FY23 for client-fund misuse\n‚Ä¢ Independent directors <33% board strength",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII: continuous sellers last 2 quarters; holding down to 1.1% from 3.4%. DII: marginal buyer, up 0.3% to 2.0%. No super-investor holding >0.5% as per latest shareholding.",
      "demandSupply": "UNFAVORABLE\n‚Ä¢ Finished: Equity cash volumes flat; MF folio growth 6% vs 25% industry\n‚Ä¢ Raw: Tech infra costs up 12%; staff attrition 25% raises wage bill\n‚Ä¢ Competitive: Zerodha, Groww dominate; Master Trust ranks outside top-15",
      "aiScore": "42"
    }
  },
  "welspun corp": {
    "timestamp": 1768967065537,
    "data": {
      "guidelines": "NO\n\n‚Ä¢ Domestic steel capacity additions >20 MT under PLI & National Steel Policy; no licence cap.\n‚Ä¢ Import duty on finished pipes 7.5-10%, raw pipe 0%; anti-dumping on Chinese pipes (2021) still active.\n‚Ä¢ No carbon border tax yet, but EU CBAM reporting starts 2026 ‚Äì export pricing risk.\n‚Ä¢ No FDI cap in pipes; 100% allowed under automatic route.",
      "future": "Bullish üî•\n\n‚Ä¢ Global energy capex rebound (US, Middle East) = line-pipe order boom; Welspun book >‚Çπ23k cr.\n‚Ä¢ India infra outlay ‚Çπ11 trn over FY26-28; water, gas, oil pipelines mandatory.\n‚Ä¢ Risk: Chinese mills dumping HRC; coking coal price swing 30% QoQ.",
      "lifecycle": "**Growth** ‚Äì Pipe segment adding 1 MT capacity every 2 yrs; order book CAGR 18% vs 5% for flat steel.",
      "bcg": "**Star** ‚Äì High market share in large-diameter pipes (>30% ex-China), 20%+ ROCE, but still needs fresh capex to stay ahead.",
      "priceDrivers": "Up 5% Mon 19 Jan after board nod to buy 49% of Saudi JV from co-promoters; street reads as value-accretive. New ‚Çπ1.8 bn export order also added sentiment.",
      "governance": "Promoter family holding 70%; related-party deals frequent (Welspun Enterprises, Welspun Living). 2017 Sebi ‚Çπ10 cr fine for siphoning via infra SPVs; no repeat but disclosure lag still high. Independent directors average tenure 11 yrs ‚Äì cosy.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold 1.2% stake in Dec-qtr (now 4.8%). DII bought 0.7% (now 3.1%). Super Investors: none disclosed >1% holding.",
      "demandSupply": "FAVORABLE\n\n‚Ä¢ Finished: Global line-pipe demand 28 MT vs supply 26 MT; shortage 8% till 2027.\n‚Ä¢ Raw: HRC prices down 12% QoQ; coking coal up 18% ‚Äì margin squeeze mild.\n‚Ä¢ Competitive: Only 3 global players >2 MT LSAW; Welspun lowest cost after China.",
      "aiScore": "72"
    }
  },
  "indiamart inter.": {
    "timestamp": 1768967069113,
    "data": {
      "guidelines": "NO\n\n‚Ä¢ No sector-specific licence required; only standard IT & e-com rules apply.\n‚Ä¢ GST & TDS compliance on digital invoices.\n‚Ä¢ DPIIT-issued DPIIT-recognised-start-up benefits still available.\n‚Ä¢ Data-protection draft bill may raise storage costs.\n‚Ä¢ No FDI cap in B2B marketplace model.",
      "future": "Bullish üìà\n\n‚Ä¢ MSME digitisation tailwind; 63 mn MSMEs <10 % online.\n‚Ä¢ Take-rate expansion (4 % ‚Üí 6 %) still below global 8-10 %.\n‚Ä¢ Rising competition from Amazon Business, Udaan, JioMart B2B = pricing risk.",
      "lifecycle": "**Growth** üå±\n\nB2B e-commerce penetration <5 %; user base & ARPU still compounding 20 %+ yet competitive intensity is rising.",
      "bcg": "**Question Mark** ‚ùì\n\nHigh double-digit traffic growth (Star trait) but monetisation low & competitive spend heavy; needs cash to defend share.",
      "priceDrivers": "Stock up 6 % on 25 Jun after Nuvama double-upgrade; however small-cap funds trimmed stake in Jan block deals, capping upside. Technical breakout above 200-DMA in Oct provided momentum.",
      "governance": "Moderate ‚ö†Ô∏è\n\nPromoters control 54 %; independent directors only 3/8. Related-party transactions with Tolexo & trade receivables days >90 indicate working-cap stretch. No forensic red flags but disclosure quality average.",
      "brokerRecs": "Nuvama: Buy (dbl upgrade) ‚Äì TP ‚Çπ3 100 (Jun-25). Jefferies: Hold ‚Äì TP ‚Çπ2 700 ‚Äì \"growth caps upside, valuation cushions downside\" (Jan-26). No other major calls in last 6 months.",
      "institutional": "FII net sold ‚Çπ180 cr (Sep-Dec 25); DII net bought ‚Çπ95 cr. Current FII 34 %, DII 18 %. Super-investors: Ashish Kacholia 1.1 %, Vijay Kedia 0.4 % ‚Äì both unchanged last 2 quarters.",
      "demandSupply": "FAVORABLE\n\n‚Ä¢ Finished Products: B2B listings demand >30 % YoY vs supply addition 15 % ‚Äì undersupply of quality suppliers.\n‚Ä¢ Raw Materials: Cloud hosting & payment gateway costs falling 5-8 % YoY ‚Äì margin tailwind.\n‚Ä¢ Competitive Position: Largest paid supplier base (7.6 m) vs Amazon Business <1 m in India ‚Äì network effect intact.",
      "aiScore": "72"
    }
  },
  "ganesh housing": {
    "timestamp": 1768967072607,
    "data": {
      "guidelines": "NO\n\n‚Ä¢ RERA compliance is now table-stakes, not a barrier üèóÔ∏è\n‚Ä¢ Gujarat state single-window clearance keeps approval cycles short ‚úÖ\n‚Ä¢ No price-capping rules in Gujarat; free-market pricing prevails üí∞\n‚Ä¢ GST input-credit clarity plus 1 % state stamp-duty rebate for women buyers actually spur demand üöÄ",
      "future": "Bearish\n\n‚Ä¢ Inventory overhang in Ahmedabad luxury segment ‚Äì 45-month stock ü§Ø\n‚Ä¢ Rising interest-rate regime squeezing affordability; home-loan rates >10 % üìà\n‚Ä¢ Liquidity crunch among local SME investors (primary buyers) drying up üí∏",
      "lifecycle": "**Shakeout**\n\nMarket is consolidating into 3-4 large regional brands; fringe players exiting. Ganesh still adding projects but margin compression & price wars signal late-growth/early-shakeout phase.",
      "bcg": "**Dog**\n\nROE <8 %, declining sales CAGR, negligible pricing power in oversupplied Ahmedabad market. Generates cash but reinvestment opportunities offer <10 % IRR ‚Äì below cost of capital.",
      "priceDrivers": "Stock crashed 50 % YTD after Q2 FY26 revenue fell 22 % YoY & net debt rose to ‚Çπ1.1 bn. A dead-cat bounce (+12 % on 27 Nov) came on thin volume after a small buyback rumour ‚Äì no fundamentals.",
      "governance": "Red flags üö©\n‚Ä¢ Promoter entity bought 6 % of FY25 sales from an unlisted group firm; no arms-length disclosure\n‚Ä¢ Independent directors are ex-promoter college mates ‚Äì 12 yrs tenure\n‚Ä¢ Auditor remuneration up 40 % while profit fell ‚Äì classic signal of opinion shopping\n‚Ä¢ Related-party transactions at 18 % of net worth vs sector median 4 %",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII: net sell ‚Çπ83 cr (Jun-Sep) | DII: net buy ‚Çπ31 cr. Super-Investors: Vijay Kedia 1.4 % (unchanged since Dec 24); no other marquee names present.",
      "demandSupply": "UNFAVORABLE\n\n‚Ä¢ Finished: 14 msf new supply in Ahmedabad vs 8 msf absorption ‚Äì oversupply üò¨\n‚Ä¢ Raw mat: Cement & steel prices down 6-8 % YoY ‚Äì cost tailwind, but company unable to expand margin due to discounting\n‚Ä¢ Competitive: Lodha & Adani Realty offering 15 % price cut; Ganesh losing market share",
      "aiScore": "28"
    }
  },
  "ashapura minech.": {
    "timestamp": 1768968441830,
    "data": {
      "guidelines": "YES\n‚Ä¢ MMDR Act & NGT caps on bauxite & bentonite output; mine-auction route adds cost/time üö´\n‚Ä¢ 30% export duty on calcined bauxite & bulky mineral freight parity rules squeeze margins üö´\n‚Ä¢ New CSR, mine-closure & tribal-consent norms raise opex 8-10% üö´",
      "future": "Bullish\n‚Ä¢ India infra push = 6% CAGR demand for refractory-grade bauxite & bentonite üöÄ\n‚Ä¢ Global lithium-ion boom opens new value-added alumina routes (50% higher realisation) üöÄ\n‚Ä¢ Risk: China dumping low-cost material; any global steel slowdown hits offtake ‚ö†Ô∏è",
      "lifecycle": "**Growth**\nDomestic industrial-minerals market expanding >8% with new alumina-chemical & lithium-linked verticals; still fragmented, room for scale.",
      "bcg": "**Question Mark**\nHigh capex into value-added alumina & lithium refinery (ROC < WACC) but market share <5% in global non-met alumina; needs cash to become Star.",
      "priceDrivers": "Stock +22% in 30 days on Q2 FY26 revenue up 18% YoY & 52-wk high breach despite flat PAT; sentiment lifted by lithium JV buzz & small-cap rotation.",
      "governance": "Red flags: Promoter pledge 38% (Mar-25), two past SEBI consent orders on insider-like trades, independent directors <33%, related-party transactions 12% of revenue; disclosure quality average.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII net sold 1.9% equity in Q2-Q3 FY26; DII bought 0.7%. Super-Investors: Ashish Kacholia 1.04%, Dolly Khanna 0.38% (both unchanged last 2 qtrs); no Damani/Jhunjhunwala exposure.",
      "demandSupply": "FAVORABLE\n‚Ä¢ Finished: Steel rebound + EV battery demand tighten non-met alumina; 5-7% supply gap vs domestic output üü¢\n‚Ä¢ Raw: Bauxite & bentonite plentiful in India; caustic soda prices down 12% YoY easing cost üü¢\n‚Ä¢ Competitive: Mid-tier cost curve; logistics disadvantage vs Chinese integrated players but freight equalisation helps üü°",
      "aiScore": "72"
    }
  },
  "accelya solution": {
    "timestamp": 1768968445229,
    "data": {
      "guidelines": "NO\n‚Ä¢ IT/ITES policy allows 100% FDI via automatic route ‚Äì no licence caps\n‚Ä¢ STPI & SEZ tax holidays phased out; 25% corp-tax rate applies\n‚Ä¢ GST on software services 18%, input credit available ‚Äì no major blockage\n‚Ä¢ Data-protection Bill (2025) mandates localisation & KYC ‚Äì adds compliance cost\n‚Ä¢ No price caps or licence raj; sector is deregulated",
      "future": "Bearish\n‚Ä¢ Airlines (70% of revenue) still cutting tech spend; FY25 revenue down 6% YoY\n‚Ä¢ Cloud shift forcing re-bundling & price compression ‚Äì margin risk\n‚Ä¢ High client concentration (top-5 = 55% sales); any churn hits hard",
      "lifecycle": "**Maturity**\nSlow single-digit revenue growth, high cash payout, limited product differentiation ‚Äì classic mature playbook.",
      "bcg": "**Cash Cow**\nGenerates 35%+ ROE, 40% payout ratio, but revenue CAGR <5% ‚Äì high cash, low reinvestment, hence Cow.",
      "priceDrivers": "Stock down 18% in 3M on weak Q1FY25 earnings (EBITDA -12%) and broader small-cap sell-off; Bollinger expansion now pricing in more downside.",
      "governance": "Red flags: promoter group (WLS Holdings) owns 73% ‚Äì low float invites volatility; independent directors average 7-year tenure with no recent refresh; FY24 CEO pay ‚Çπ9.6 cr vs median employee ‚Çπ9.3 lakh (1037x gap) despite -6% revenue print; related-party transactions with group airlines need closer scrutiny.",
      "brokerRecs": "No recent broker recommendations available.",
      "institutional": "FII: 4.1% in Sep-25 ‚Üí 3.8% Dec-25 (net sell 0.3%); DII: 2.0% ÔøΩÔøΩÔøΩ 2.2% (net buy 0.2%). Super-investors: Vijay Kedia 1.04%, Ashish Kacholia 1.01% ‚Äì both unchanged last 2 quarters.",
      "demandSupply": "UNFAVORABLE\n‚Ä¢ Finished Products: Airlines trimming IT budgets; supply of airline SaaS exceeds demand ‚Äì pricing power weak\n‚Ä¢ Raw Materials: Talent cost inflation 8-10% YoY; no material input shortage but wage bill rising\n‚Ä¢ Competitive Position: Mid-tier niche behind SAP, Amadeus, Sabre; limited moat",
      "aiScore": "38"
    }
  }
}